By Ben Glickman
Sorrento Therapeutics said director Tammy Reilly resigned Oct. 25 citing a lack of communication from the bankrupt company’s chief restructuring officer.
The pharmaceutical company said in a regulatory filing Friday that Reilly also cited the “general operating of the company” and modifications to the company’s directors’ and…
Read the full article here